Test for CMV reactivation risk during ulcerative colitis flare
Treatments studied
Part of Digestive system, Infections clinical trials.
This study checks whether a blood test (QuantiFERON-CMV, related to prior CMV infection) can predict if CMV might reactivate during a severe ulcerative colitis flare. It may help doctors spot people at higher risk and potentially guide monitoring and treatment during hospitalization.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a past CMV infection (blood test shows CMV IgG positive)
- You are currently being admitted to the hospital for an ulcerative colitis flare
- Your ulcerative colitis flare is severe (Mayo score above 5 and endoscopy score at least 2)
- You have health coverage/insurance through the social security system
- You can understand the study and sign the consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test (QuantiFERON-CMV) to help decide whether people with a silent (no symptoms) CMV infection after a solid organ transplant need treatment. If you have a low-to-moderate level of CMV in your blood without fever or organ issues, this trial may help your doctor choose the safest approach.
This study looks at how well a new blood test detects cytomegalovirus (a common virus) in people who have had a stem cell transplant. The test may help doctors catch the virus early and treat it faster.
This trial is for adults who have had a stem cell transplant and now have their first CMV infection. It tests a way to measure your immune response to CMV, which may help doctors decide the best treatment for you.
This study looks at how certain blood cells change during a severe flare-up of inflammatory bowel disease (IBD), like Crohn's disease or ulcerative colitis. The goal is to better understand inflammation and potentially improve future treatments.
This trial compares different diagnostic tests to find the best way to detect cytomegalovirus (CMV) organ disease in people with inflammatory bowel disease (IBD) whose symptoms get worse and need hospital care. The goal is to improve diagnosis and treatment for this complication.
This study tests a new way to monitor ulcerative colitis using stool tests and colonoscopy to detect early signs of cancer. It may help doctors manage long-term ulcerative colitis more safely.
Hear when a new Cytomegalovirus Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.